Cite
HARVARD Citation
Tavassoly, I. et al. (2019). Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses. Molecular oncology. 13 (8), pp. 1725-1743. [Online].